Indication
Charcot Arthropathy
2 clinical trials
2 products
Clinical trial
RANKL Antibody (Danosumab) for Acute Charcot Neuro-osteoarthropathy Remission in Chronic Kidney DiseaseStatus: Completed, Estimated PCD: 2023-03-31
Product
DanosumabClinical trial
Efficacy of Treatment With DENOsumab of an Acute CHARCOT Foot in Patients With Diabetes. A Multicenter, Double-blind, Randomized, Placebo-controlled Trial.Status: Recruiting, Estimated PCD: 2025-10-01
Product
Denosumab